n-methyl-3,4-methylenedioxyamphetamine has been researched along with 6-cyano-7-nitroquinoxaline-2,3-dione in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Finnegan, KT; Taraska, T | 1 |
Aguilar, MA; García-Pardo, MP; Miñarro, J | 1 |
2 other study(ies) available for n-methyl-3,4-methylenedioxyamphetamine and 6-cyano-7-nitroquinoxaline-2,3-dione
Article | Year |
---|---|
Effects of glutamate antagonists on methamphetamine and 3,4-methylenedioxymethamphetamine-induced striatal dopamine release in vivo.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Amines; Animals; Corpus Striatum; Dizocilpine Maleate; Dopamine; Excitatory Amino Acid Antagonists; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Pipecolic Acids; Rats; Rats, Sprague-Dawley | 1996 |
Role of AMPA glutamate receptors in the conditioned rewarding effects of MDMA in mice.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Amphetamine-Related Disorders; Animals; Conditioning, Psychological; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Hallucinogens; Male; Mice; N-Methyl-3,4-methylenedioxyamphetamine; Receptors, AMPA; Reward; Spatial Behavior | 2018 |